58b0b5f8d80438000408a981_logo.jpg
Nemus Bioscience Adds to Senior Leadership Team
May 07, 2018 08:30 ET | Nemus Bioscience, Inc.
LONG BEACH, CA, May 07, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Emerald Logo.png
Prominent Salk Institute Neuroscientist Joins Nemus Bioscience as Scientific Consultant
March 21, 2018 08:30 ET | Nemus Bioscience, Inc.
Dr. David Schubert to advise Nemus on neuroprotection and CNS applications of the company’s proprietary cannabinoid portfolio COSTA MESA, CA. , March 21, 2018 (GLOBE NEWSWIRE) -- Nemus...
Emerald Logo.png
NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences
March 07, 2018 08:30 ET | Nemus Bioscience, Inc.
COSTA MESA, CA., March 07, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Emerald Logo.png
Emerald Health, Strategic Majority Investor in Nemus Bioscience, Completes Final Closing of Private Placement Investment Ahead of Schedule
February 16, 2018 17:24 ET | Nemus Bioscience, Inc.
Nemus Bioscience Receives $1,750,000 Private Placement to Help Advance Innovative Bio-engineered Cannabinoid Pipeline Costa Mesa, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
Emerald Logo.png
NEMUS Bioscience to Participate in BIO CEO Investor Conference to Provide Ophthalmology-Focused Pipeline Review
February 07, 2018 08:30 ET | Nemus Bioscience, Inc.
COSTA MESA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Emerald Logo.png
Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics
January 19, 2018 08:30 ET | Nemus Bioscience, Inc.
Nemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement COSTA MESA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
Emerald Logo.png
Nemus Bioscience Announces Closing of Convertible Bridge Loan and Anticipated Equity Financing
December 29, 2017 08:30 ET | Nemus Bioscience, Inc.
COSTA MESA, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS, “Nemus”) today announced that it entered into agreements with Emerald Health Sciences Inc. (“Emerald”),...